We are live on ! Find out more
PSTV

Plus Therapeutics
PSTV

Delisted

PSTV was delisted on the 31st of July, 2026.

Back to rankings

14 hedge funds and large institutions have $4.11M invested in Plus Therapeutics in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

473% more capital invested

Capital invested by funds: $718K → $4.11M (+$3.4M)

200% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 3

75% more funds holding

Funds holding: 8 → 14 (+6)

0.01% more ownership

Funds ownership: 0.01% → 0.02% (+0.01%)

Holders
14
Holders Change
+6
Holders Change %
+75%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
4
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.53M
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$315K
3
Two Sigma Advisers
Two Sigma Advisers
New York
+$276K
4
Two Sigma Investments
Two Sigma Investments
New York
+$261K
5
VF
Virtu Financial
New York
+$183K

Top Sellers

Rank Fund Capital Flow
1
BRWM
B. Riley Wealth Management
Tennessee
-$29K
2
TRCT
Tower Research Capital (TRC)
New York
-$5K
3
Bank of America
Bank of America
North Carolina
-$3.61K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.82M +$1.53M +1,695 +823%
Two Sigma Advisers
2
Two Sigma Advisers
New York
$449K +$276K +305 +187%
BlackRock
3
BlackRock
New York
$410K +$93.1K +103 +32%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$334K +$315K +349 New
Two Sigma Investments
5
Two Sigma Investments
New York
$278K +$261K +289 New
VF
6
Virtu Financial
New York
$195K +$183K +203 New
Dimensional Fund Advisors
7
Dimensional Fund Advisors
Texas
$175K +$164K +182 New
Citadel Advisors
8
Citadel Advisors
Florida
$111K +$105K +116 New
Northern Trust
9
Northern Trust
Illinois
$104K +$97.6K +108 New
State Street
10
State Street
Massachusetts
$88K +$82.2K +91 New
Creative Planning
11
Creative Planning
Kansas
$47K +$4.52K +5 +11%
Renaissance Technologies
12
Renaissance Technologies
New York
$45K +$42.5K +47 New
SFI
13
Susquehanna Fundamental Investments
Pennsylvania
$33K +$31.6K +35 New
Osaic Holdings
14
Osaic Holdings
Arizona
$20K – – –
FP
15
Financial Perspectives
Minnesota
$3 – – –
BRWM
16
B. Riley Wealth Management
Tennessee
– -$29K -32 Closed
TRCT
17
Tower Research Capital (TRC)
New York
– -$5K -5 Closed
Bank of America
18
Bank of America
North Carolina
– -$3.61K -4 Closed

PSTV Hedge Fund Activity: Q2 2021 in Review

14 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q2 2021, worth a combined $4.11M — up 473% from $718K a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new PSTV positions and 3 closed out — a net gain of 6 holders — while 4 added to existing stakes and 0 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.53M. The largest seller was B. Riley Wealth Management, exiting entirely with an estimated $29K sold.

  • 14 institutional investors held Plus Therapeutics (PSTV) as of Q2 2021, up from 8 in Q1 2021.
  • Funds reported $4.11M of Plus Therapeutics stock for Q2 2021, up 473% quarter-over-quarter.
  • 9 funds opened new Plus Therapeutics positions in Q2 2021 and 3 closed out, a net change of +6 holders.
  • The largest Plus Therapeutics buyer in Q2 2021 was Vanguard Group, an estimated $1.53M added.
  • The largest Plus Therapeutics seller in Q2 2021 was B. Riley Wealth Management, an estimated $29K sold.

Based on aggregated 13F filings for Q2 2021.